Bosentan
Bosentan is a prescription medication used to treat pulmonary arterial hypertension (PAH), a condition where blood pressure in the lungs is too high. It works by blocking endothelin receptors to relax blood vessels. Available as oral tablets in 62.5 mg and 125 mg strengths, manufactured by Zydus Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bosentan is a prescription medication used to treat pulmonary arterial hypertension (PAH), a condition where blood pressure in the lungs is too high. It works by blocking endothelin receptors to relax blood vessels. Available as oral tablets in 62.5 mg and 125 mg strengths, manufactured by Zydus Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bosentan",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bosentan — ANDA 213154 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213154"
}
]
|
| identifier | ANDA213154 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bosentan |
